Cleo Diagnostics (ASX:COV) EV-to-Revenue : (As of May. 23, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Cleo Diagnostics EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Cleo Diagnostics's enterprise value is A$23.21 Mil. Cleo Diagnostics does not have enough years/quarters to calculate its Revenue for the trailing twelve months (TTM) ended in Dec. 2023. Therefore, GuruFocus does not calculate Cleo Diagnostics's EV-to-Revenue at this moment.

The historical rank and industry rank for Cleo Diagnostics's EV-to-Revenue or its related term are showing as below:

ASX:COV's EV-to-Revenue is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 3.24
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-23), Cleo Diagnostics's stock price is A$0.17. Cleo Diagnostics does not have enough years/quarters to calculate its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023. Therefore, GuruFocus does not calculate Cleo Diagnostics's PS Ratio at this moment.

Cleo Diagnostics EV-to-Revenue Historical Data

The historical data trend for Cleo Diagnostics's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cleo Diagnostics EV-to-Revenue Chart

Cleo Diagnostics Annual Data

Trend

Jun23

EV-to-Revenue

Cleo Diagnostics Semi-Annual Data
	Dec22	Jun23	Dec23
EV-to-Revenue	-	-	-

Competitive Comparison of Cleo Diagnostics's EV-to-Revenue

For the Medical Devices subindustry, Cleo Diagnostics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cleo Diagnostics's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cleo Diagnostics's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Cleo Diagnostics's EV-to-Revenue falls into.

Cleo Diagnostics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Cleo Diagnostics's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	23.205	/
	=

Cleo Diagnostics (ASX:COV) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Cleo Diagnostics's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.17	/
	=

Cleo Diagnostics EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cleo Diagnostics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Cleo Diagnostics (ASX:COV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cleo Diagnostics Ltd (ASX:COV) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

480 Collins Street, Level 2, Melbourne, VIC, AUS, 3000

Website

https://www.cleodx.com

Cleo Diagnostics Ltd is focused on the development of non-invasive blood-based IVD tests to detect the presence, and recurrence, of ovarian cancer. The Company's first product to market is intended to be the Triage Test which has to date produced strong results to accurately differentiate patients with malignant ovarian cancer from those with benign gynaecological conditions. The Company aims to improve the diagnostic process and procedures for detecting ovarian cancer and, in this regard, improve quality-of-life outcomes for patients who have been diagnosed with ovarian cancer.

Cleo Diagnostics (ASX:COV) Headlines

No Headlines